Literature DB >> 4006383

Long-term second-line therapy in rheumatoid arthritis.

H A Bird.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006383     DOI: 10.1007/bf02032281

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  10 in total

1.  Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment.

Authors:  R Luukkainen; A Kajander; H Isomäki
Journal:  Scand J Rheumatol       Date:  1977       Impact factor: 3.641

2.  A controlled trial of cyclophosphamide in rheumatoid arthritis.

Authors: 
Journal:  N Engl J Med       Date:  1970-10-22       Impact factor: 91.245

3.  A human model screening system for the detection of specific antirheumatic activity.

Authors:  J S Dixon; H A Bird; M E Pickup; V Wright
Journal:  Semin Arthritis Rheum       Date:  1982-11       Impact factor: 5.532

4.  Does the addition of ketotifen to non-steroidal anti-inflammatory drugs confer any additional benefit in rheumatoid arthritis?

Authors:  L G Teh; R Madhok; H A Capell
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

5.  Quantitation of the activity of rheumatoid arthritis. 5. A method for summation of the systemic indices of rheumatoid activity.

Authors:  J LANSBURY
Journal:  Am J Med Sci       Date:  1956-09       Impact factor: 2.378

6.  Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

Authors:  V C Neumann; K A Grindulis; S Hubball; B McConkey; V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

7.  Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

8.  Second line therapy in rheumatoid arthritis--a four year prospective study.

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

9.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11

10.  Measurement of patient outcome in arthritis.

Authors:  J F Fries; P Spitz; R G Kraines; H R Holman
Journal:  Arthritis Rheum       Date:  1980-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.